Heart Disease News and Research

Latest Heart Disease News and Research

Consumer Reports rates heart bypass surgical groups

The New York Times: Consumer Reports will rate groups that perform heart bypass surgery. The group already rates many consumer items like cars and even household appliances. "In most parts of the country, data-based ratings of doctors are not available to patients. Only a few states, including New York, provide them.

9 Sep 2010

Arcapita enters equity investment, option to purchase agreement with St. Jude Medical

Arcapita, a global investment company, announced today that Atlanta-based CardioMEMS, an Arcapita Ventures portfolio company, has entered into an equity investment and option to purchase agreement with St. Jude Medical, a global medical device company.

9 Sep 2010

Shared needle at school science experiment puts students at risk

In a science experiment at a Tasmanian Dover District high school, a teacher took blood samples from grade 9 and 10 students using the same needle. They were testing blood pH levels. Now students are being tested for HIV infection. The needle was dipped in methylated spirits each time before pricking but authorities say this is not enough to prevent transmission of HIV and other viruses like Hepatitis B and C.

8 Sep 2010

MAP Pharmaceuticals completes 12 months of treatment in LEVADEX open-label safety trial

MAP Pharmaceuticals, Inc. today announced that all non-asthmatic patients and a subset of asthmatic patients have completed 12 months of treatment in the open-label safety trial of LEVADEX™. In addition, the Company has completed patient treatment in a thorough QT trial, the last trial necessary to support a New Drug Application (NDA) for LEVADEX.

8 Sep 2010

MAP Pharmaceuticals reports results from PD trial that compares effects of LEVADEX, IV DHE

MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.

8 Sep 2010

Columbus Regional Hospital joins Indiana Network for Patient Care

Columbus Regional Hospital is bringing the nation's largest health information exchange to the Columbus, Ind. area to better serve patients. Joining over 65 hospitals, long term care facilities and other healthcare providers, Columbus Regional Hospital is now part of a statewide network that allows physicians to securely access necessary information to make decisions critical to patient care.

8 Sep 2010

McLeod Health implements Merge Healthcare's radiology, cardiology workflow solutions

Merge Healthcare, a leading health IT solutions provider, today announced a new contract with McLeod Health (Florence, SC). This agreement integrates the Merge cardiology workflow solutions with McLeod's existing Merge radiology solution, allowing McLeod to streamline workflow and improve quality data across their entire cardiovascular service line, while also providing a unified image management platform.

8 Sep 2010

First Edition: September 8, 2010

In today's headlines, reports about how health reform is playing on the campaign trail and the latest on health insurance premium hikes.

8 Sep 2010

Late breaking clinical trials in interventional cardiovascular medicine to be presented at TCT 2010

Clinical trials in a variety of areas within interventional cardiovascular medicine that will be presented at TCT 2010 will directly affect the way that people with cardiovascular disease are treated. Breakthroughs in science and medical research, presented exclusively at TCT, will lead to new treatments that are minimally invasive and involve shorter recovery times. Among the topics being covered are stenting in the femoral artery, polymer-free drug-eluting stents, valves and drug-eluting balloons used in angioplasty.

8 Sep 2010

PPD establishes preferred provider relationships for conducting Phase I trials

PPD, Inc. today announced it has established preferred provider relationships with a network of sites across North America for conducting Phase I trials in patients to meet growing client demand for these services.

8 Sep 2010

FDA clears Viking Systems' Next Generation 3DHD visualization system

Viking Systems, Inc. announced today that it has received clearance of its 510(k) application by the Food and Drug Administration related to its Next Generation 3DHD visualization system. The System is scheduled for market launch in Washington D.C. at this year's American College of Surgeons' Annual Clinical Congress which will be held from October 3-7.

8 Sep 2010

Reports on smoking rates among Americans reveal dramatic progress in fight against tobacco

Two new reports released today by the Centers for Disease Control and Prevention show that while the United States has made dramatic progress in the fight against tobacco, too many Americans still smoke and too many non-smokers including more than half of all young children are still exposed to secondhand smoke.

8 Sep 2010

NIH announces $161.3 million for expansion of Pharmacogenomics Research Network

The National Institutes of Health plans to spend $161.3 million over the next five years to expand the Pharmacogenomics Research Network (PGRN), a nationwide collaborative of scientists focused on understanding how genes affect a person's response to medicines.

8 Sep 2010

Researchers find blebbistatin chemically inhibits NMII, enhances survival of stem cells

Human pluripotent stem (hPS) cells can generate any given cell type in the adult human body, which is why they are of interest to stem cell scientists working on finding therapies for spinal cord injuries, Parkinson's disease, burns, heart disease, diabetes, arthritis, and other ailments.

8 Sep 2010

NIH announces $15 million for expansion of Pharmacogenomics Knowledge Base

To help advance research on how genes affect responses to medicines, the National Institutes of Health is spending $15 million over five years to expand a key resource, the Pharmacogenomics Knowledge Base (PharmGKB), http://www.pharmgkb.org/ .

8 Sep 2010

Progerin may contribute to risk of atherosclerosis: Study

Progeria, also known as Hutchinson-Gilford Progeria Syndrome (HGPS), is a rare, fatal genetic disease characterized by an appearance of accelerated aging in children. All children with Progeria die of the same heart disease that affects millions of normal aging adults (atherosclerosis), but instead of occurring at 60 or 70 years of age, these children may suffer heart attacks and strokes even before age 10, and the average age of death is 13 years.

8 Sep 2010

TransOral Robotic Surgery removes head and neck cancer tumors, while preserving speech

An incisionless robotic surgical procedure is offering patients a new option to remove certain head and neck cancer tumors without visible scarring, while preserving speech and the ability to eat.

8 Sep 2010

Study suggests better quality primary care improves health

Financial incentives in primary care cut heart disease deaths and hospital admissions, particularly among people from deprived areas, finds research published online in the Journal of Epidemiology and Community Health.

8 Sep 2010

Israeli Supreme Court dismisses Taro's appeal in favor of Sun Pharma

Sun Pharmaceutical Industries Ltd. today announced that the Supreme Court of Israel has unanimously dismissed the appeal by Taro Pharmaceutical Industries Ltd. of the previous ruling by the Tel-Aviv District Court holding that the Israeli special tender offer (STO) rules do not apply to the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd., to purchase all outstanding Ordinary Shares of Taro for USD 7.75 net per Ordinary Share in cash.

8 Sep 2010

Lack of sleep likely to develop diabetes, heart disease: Research

People who sleep less than six hours a night may be three times more likely to develop a condition which leads to diabetes and heart disease, according to researchers at the University of Warwick.

8 Sep 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Consumer Reports rates heart bypass surgical groups

Arcapita enters equity investment, option to purchase agreement with St. Jude Medical

Shared needle at school science experiment puts students at risk

MAP Pharmaceuticals completes 12 months of treatment in LEVADEX open-label safety trial

MAP Pharmaceuticals reports results from PD trial that compares effects of LEVADEX, IV DHE

Columbus Regional Hospital joins Indiana Network for Patient Care

McLeod Health implements Merge Healthcare's radiology, cardiology workflow solutions

First Edition: September 8, 2010

Late breaking clinical trials in interventional cardiovascular medicine to be presented at TCT 2010

PPD establishes preferred provider relationships for conducting Phase I trials

FDA clears Viking Systems' Next Generation 3DHD visualization system

Reports on smoking rates among Americans reveal dramatic progress in fight against tobacco

NIH announces $161.3 million for expansion of Pharmacogenomics Research Network

Researchers find blebbistatin chemically inhibits NMII, enhances survival of stem cells

NIH announces $15 million for expansion of Pharmacogenomics Knowledge Base

Progerin may contribute to risk of atherosclerosis: Study

TransOral Robotic Surgery removes head and neck cancer tumors, while preserving speech

Study suggests better quality primary care improves health

Israeli Supreme Court dismisses Taro's appeal in favor of Sun Pharma

Lack of sleep likely to develop diabetes, heart disease: Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in